Sign Up Today and Learn More About Caristo Diagnostics Stock
Invest in or calculate the value of your shares in Caristo Diagnostics or other pre-IPO companies through EquityZen's platform.
![Caristo Diagnostics](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/caristodiagnostics_logo-62fc210b1893b5e0.png)
Caristo Diagnostics Stock
Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.
About Caristo Diagnostics Stock
Founded
2018
Industries
Science and Engineering, Health Care, Biotechnology
Caristo Diagnostics Press Mentions
Stay in the know about the latest news on Caristo Diagnostics
New AI tech predicts cardiac events due to coronary inflammation
longevity • Jun 25, 2024
Newsweek Selects Caristo Diagnostics as One of World's Best Digital Health Companies
prnewswire • Jun 25, 2024
The Lancet Publishes Results from World's Largest Coronary CT Registry Showing New AI Technology Can Predict ...
prnewswire • Jun 25, 2024
Newsweek Selects Caristo Diagnostics as One of World's Best Digital Health Companies
finance • May 23, 2024
Identifying inflammation is at the heart of the matter
longevity • May 23, 2024
Caristo Diagnostics Management
Leadership team at Caristo Diagnostics
Board Member
Matthew Frohn
Board Member
Heather Roxborough
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Caristo Diagnostics current valuation
- Caristo Diagnostics stock price
- Available deals in Caristo Diagnostics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Caristo Diagnostics stock?
Accredited investors can buy pre-IPO stock in companies like Caristo Diagnostics through EquityZen funds. These investments are made available by existing Caristo Diagnostics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Caristo Diagnostics stock?
Shareholders can sell their Caristo Diagnostics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."